21 research outputs found
Photochemical Cleavage of Benzylic C–N Bond To Release Amines
The 3-(diethylamino)Âbenzyl (DEABn)
group has been studied for releasing
primary, secondary, and tertiary amines by direct photochemical breaking
of the benzylic C–N bond. While photochemical release of primary
and secondary amines provides high yields in methanol, release of
tertiary amines in MeCN/water can improve yields and reduce the undesired
dealkylation side reaction
Structurally Simple Benzylidene-Type Photolabile Diol Protecting Groups
Two structurally simple photolabile
protecting groups for releasing
1,2- and 1,3-diols have been developed. The diols can be protected
in high yields and released from their corresponding acetals with
high chemical efficiency
Photochemical Formation and Cleavage of C–N Bond
A new
photochemical method of C–N bond formation has been
developed. A properly substituted trityl alcohol can cleave the benzylic
C–O bond and replace it with a C–N bond which is stable
under the irradiation conditions. The C–N bond can then be
photochemically cleaved with the same light source when the nitrogen
is protonated
Synthesis and Evaluation of QS-21-Based Immunoadjuvants with a Terminal-Functionalized Side Chain Incorporated in the West Wing Trisaccharide
Three QS-21-based
vaccine adjuvant candidates with a terminal-functionalized
side chain incorporated in the west wing trisaccharide have been synthesized.
The terminal polar functional group serves to increase the solubility
of these analogues in water. Two of the synthetic analogues have been
shown to have adjuvant activity comparable to that of GPI-0100. The
stand-alone adjuvant activity of the new synthetic analogues again
confirmed that it is a feasible way to develop new saponin-based vaccine
adjuvants through derivatizing at the west wing branched trisaccharide
domain. Inclusion of an additional polar functional group such as
a carboxyl group (as in <b>3x</b>) or a monosaccharide (as in <b>4x</b> and <b>5x</b>) is sufficient to increase the water
solubility of the corresponding synthetic analogues to a level comparable
to that of GPI-0100 and suitable for immunological studies and clinical
application. The structure of the incorporated side chain has a significant
impact on the adjuvant activity in terms of the magnitude and nature
of the host’s responses